Sangamo Therapeutics
SGMO
#8849
Rank
S$0.19 B
Marketcap
S$0.58
Share price
-1.98%
Change (1 day)
-77.40%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: S$0.19 Billion

As of December 2025 Sangamo Therapeutics has a market cap of S$0.19 Billion. This makes Sangamo Therapeutics the world's 8849th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025S$0.19 B-73.07%
2024S$0.72 B470.55%
2023S$0.12 B-81.55%
2022S$0.68 B-53.3%
2021S$1.47 B-49.42%
2020S$2.91 B123.13%
2019S$1.30 B-18.34%
2018S$1.60 B-13.56%
2017S$1.85 B494.69%
2016S$0.31 B-65.69%
2015S$0.90 B-34.54%
2014S$1.38 B26.71%
2013S$1.09 B180.9%
2012S$0.38 B102.06%
2011S$0.19 B-50.28%
2010S$0.38 B3.79%
2009S$0.37 B83.36%
2008S$0.20 B-73%
2007S$0.75 B112.98%
2006S$0.35 B72.9%
2005S$0.20 B-17.07%
2004S$0.24 B6.66%
2003S$0.23 B79.48%
2002S$0.12 B-69.47%
2001S$0.42 B-43.45%
2000S$0.74 B

End of Day market cap according to different sources

On Dec 12th, 2025 the market cap of Sangamo Therapeutics was reported to be:

S$0.19 Billion
by Nasdaq info icon info icon
S$0.19 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
S$192.92 B 98,559.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$67.82 B 34,585.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$220.95 B 112,893.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$32.98 B 16,767.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
S$22.00 B 11,151.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$658.30 B 336,546.55%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$13.22 B 6,663.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$323.53 B 165,349.43%๐Ÿ‡บ๐Ÿ‡ธ USA